ABSTRACT: Pathological conditions with refractory skeletal pain are often characterized by regional osteoporotic changes such as transient osteoporosis of the hip, regional migratory osteoporosis, or complex regional pain syndrome (CRPS). Our previous study demonstrated that the acidic microenvironment created by osteoclast activation under high bone turnover conditions induced pain-like behaviors in ovariectomized mice through the stimulation of acid-sensing nociceptors. The aim of the present study was to examine whether regional transient osteoporotic changes are related to pain-like behaviors in the hind limb using tail-suspended model mice. The hind limbs of tail-suspended mice were unloaded for 2 weeks, during which time the mice revealed significant regional osteoporotic changes in their hind limbs accompanied by osteoclast activation. In addition, these changes were significantly recovered by the resumption of weight bearing on the hind limbs for 4 weeks. Consistent with the pathological changes in the hind limbs, pain-like behaviors in the mice were induced by tail suspension and recovered by the resumption of weight bearing. Moreover, treatment with bisphosphonate significantly prevented the triggering of the regional osteoporosis and pain-like behaviors, and antagonists of the acidsensing nociceptors, such as transient receptor potential channel vanilloid subfamily member 1 and acid-sensing ion channels, significantly improved the pain-like behaviors in the tail-suspended mice. We, therefore, believe that regional transient osteoporosis due to osteoclast activation might be a trigger for the pain-like behaviors in tail-suspended model mice. ß
Regional osteoporosis is characterized by chronic skeletal pain and the development of localized osteoporotic changes in the periarticular bone. These clinical and radiological features are found in conditions associated with chronic skeletal disease with refractory limb pain such as transient osteoporosis of the hip, regional migratory osteoporosis, or complex regional pain syndrome (CRPS). [1] [2] [3] [4] [5] [6] Transient osteoporosis of the hip is a rare self-limiting condition that involves the acute onset of hip pain and diffuse osteoporotic changes in the femoral head and neck without a history of major trauma.
1,2 Regional migratory osteoporosis presents as an idiopathic migrating arthralgia of the weightbearing joints of the lower limbs associated with severe focal osteoporosis at the involved site, 3, 4 which was reported to share the same disease process as transient osteoporosis of the hip. 5 CRPS, also known as reflex sympathetic dystrophy, usually develops after trauma and immobilization, and is characterized by focal pain, hyperalgesia, autonomic disturbance, and bone osteoporotic changes such as regional osteoporosis. 6, 7 These diseases may have a common pathogenesis and could respond to similar treatment with regard to acute local osteoporotic changes, although their etiology remains uncertain. In fact, several studies have demonstrated that bisphosphonate, an effective anti-osteoporosis agent, improved the pain and regional osteoporosis associated with these diseases. [8] [9] [10] We have previously reported two cases of CRPS type I without any associated trigger events. The patients presented with severe foot or ankle pain with marked regional osteoporotic changes. Interestingly, the severe pain and regional osteoporosis were markedly improved by treatment with low-dose oral bisphosphonate. 11 Furthermore, we demonstrated that ovariectomized (OVX) mice with osteoporosis have increased skeletal pain in comparison with normal mice, and the pain can be improved by treatment with bisphosphonate. 12 In addition, the increased skeletal pain in OVX mice was also improved by the administration of an antagonist to transient receptor potential channel vanilloid subfamily member 1 (TRPV1) or acid sensing ion channels (ASICs), which are the two main classes of acid-sensing nociceptors, and an inhibitor of vacuolar H þ -ATPase, the secretion of protons by which is known to be an acidification pathway during bone resorption by osteoclasts. 13 Based on these results, we speculated that the acidic microenvironment created by osteoclasts under high bone turnover conditions increases bone pain in OVX model mice through the activation of acid-sensing receptors such as TRPV1 or ASIC. These studies encouraged us to undertake further experiments to elucidate whether regional osteoporosis could also be caused by the acidic microenvironment created by activated osteoclasts under increased bone resorption conditions.
The aim of the present study was, therefore, to examine whether regional osteoporosis induced skeletal pain using tail-suspended mice, 14 a model of regional osteoporosis in the hind limbs. In addition, we examined whether the skeletal pain associated with regional osteoporosis can be improved by the resumption of weight bearing on the hind limbs, and whether treatment with bisphosphonate or acid-sensing nociceptor antagonists improves the skeletal pain.
MATERIALS AND METHODS

Animals
The present experiments were approved by the Sapporo Medical University Animal Care Committee and were undertaken in accordance with the ethical guidelines of the National Institute of Health. Every effort was made to minimize animal suffering and the number of animals used. Experiments were conducted on 8-week-old male C57BL/6J mice weighing 20-25 g (Japan SLC, Hamamatsu, Japan). The mice were housed in a temperature-controlled room (21 AE 1˚C) with a 12 h light/dark cycle and were given free access to food and water. The animals were humanely sacrificed with an intraperitoneal injection of pentobarbital sodium (0.5 mg/kg) after completion of the experiments. We used a total of 148 mice, consisting of 86 tail-suspended and 62 control mice. In this study, two kinds of control mice were used, one in which the mice were tail-suspended but the hind limbs were free to be loaded (loaded mice), and another in which the mice were freely housed without any tail suspension (control mice). The tibia and humerus were removed at 2 weeks after the start of tail suspension and at 4 weeks after the resumption of weight bearing, and microcomputed tomography (mCT), measurement of femur and serum tartrate-resistant acid-phosphatase 5b (TRAP5b) level, and histological analysis were performed.
Tail-Suspension Model
Hind limb unloading was accomplished as described by Wronski and Morey-Holton with some modifications. 15 We used minimal restraints to avoid the risk of stress during the hind limb unloading procedure. Briefly, the tail was cleaned with alcohol and allowed to dry. The tail was then varnished with instant adhesive (ARON ALPHA; Toagosei Co., Ltd., Tokyo, Japan), and a tape was applied to the surface of the tail and attached to a metal clip. The end of the clip was then fixed to an overhead bar and the length of the tape was adjusted to maintain the mice at a head-down tilt of 30ẘ ith the hind limbs elevated above the floor of the cage. To facilitate free movement about the cage, the clip was attached to a swivel anchored to the cage so as to allow a 360˚range of movement. The hind limb-unloaded mice were subjected to tail suspension with the hind limbs elevated for 2 weeks. After 2 weeks, the hind limbs were re-loaded for 4 weeks.
Body Weight of the Animals
The body weight of the mice was measured during the experimental period to monitor the effects of tail suspension on general body condition. There were no significant changes in body weight in any of the groups during the course of the experiments. This confirmed that the stress on the mice in our experiments could be regarded as minimal, as previously described. 16, 17 Anxiety Testing of the Animals A social interaction test was conducted to measure social behavior in a novel environment 18, 19 for confirmation that the mice were exposed to minimal stress. Briefly, weightmatched (within 5 g) mice of the same genotype, which had been housed in different cages, were place into an acrylic box together (40 Â 40 Â 30 cm) and allowed to explore freely for 10 min at 2 weeks after the start of tail suspension. In the test, the total number of contacts, total duration of contacts, total duration of active contacts, and mean duration per contact were measured. We regarded an "active contact" to occur when the two mice made contact with each other and the distance traveled by either mouse was greater than 5 cm.
Evaluation of Bone Micro-Architecture by mCT
The isolated proximal tibia and proximal humerus were scanned on a mCT system (ScanXmate-L090, Comscantecno, Yokohama, Japan) that was operated at a lamp voltage of 75 kV and a current of 100 mA using X sys FP Version 1.7 and coneCTexpressIV 1.32 (Comscantecno) software. Samples were scanned at a magnification factor of 10.9 and a spatial resolution of 9.171 mm/pixel. Captured images were rendered using the TRI/3D BON (Ratoc System Engineering Co., Ltd., Tokyo, Japan) software. Osteoporotic evaluation was performed on the basis of bone surface to bone volume ratio (BS/BV, 1/mm), trabecular thickness (Tb.Th, mm), and bone volume fraction (BV/TV, %).
Measurements of Femur Bone-Marrow and Serum
Tartrate-Resistant Acid-Phosphatase 5b (TRAP5b) Levels Bone and blood samples were collected at 2 weeks after the start of tail suspension and 4 weeks after the resumption of weight bearing. The right femoral bone samples were taken and cleaned of all soft tissues, which was used for the assay of TRAP5b as a bone resorption marker. The femurs were homogenized in 300 ml physiological saline, at 40000 rpm/ 30 s Â 2 times using a bread crusher. The homogenates were centrifuged at 15000g for 10 min at 4˚C and the supernatants were then extracted. TRAP5b values were measured using a mouse TRAP5b enzyme-linked immune sorbent assay kit (Immunodiagnostic Systems, London, UK) in accordance with the manufacturer's recommendations.
Histological Analysis
The left femoral bone samples were used for histological analysis including osteoclast counting. Left femur samples from four mice were obtained at each time point: prior to the start of tail suspension, 2 weeks after the start of tail suspension and 4 weeks after the resumption of weight bearing. The samples were fixed in 10% neutral-buffered formalin for 1 day, decalcified in 0.5 M ethylene diamine tetraacetic acid for 3 days, and embedded in paraffin. Paraffin sections were cut on the sagittal plane at a thickness of 4 mm. The sections of each femur were stained with hematoxylin and eosin (H-E). Slide images were captured using a Super Coolscan 5000 ED system (Nikon, Tokyo, Japan). The number of osteoclasts was counted in four randomly selected fields per femur with the observer was blinded to the treatment regimen received by the mice.
Assessment of Pain-Like Behavior
Behavioral tests were performed as previously described 12, 13 prior to tail suspension and every week after the start of tail suspension and resumption of weight bearing. In brief, thermal nociceptive testing (paw-flick test) was conducted using an analgesimeter (Plantar test 7370, Ugo Basile, Italy). The mice were placed in plastic chambers (6 Â 4 Â 4 cm) and left unrestrained. Radiant heat was applied to the plantar surface of the left fore-and hind-paws until it was actively withdrawn by the animal. Paw withdrawal latency (PWL) was considered to be an index of the thermal nociceptive threshold, and a decrease in this measurement indicated ASIC-RELATED OSTEOPOROTIC BONE PAIN thermal hyperalgesia. Light beam intensity was adjusted so that the basal PWL was 7-10 s. The cut-off time was set at 15 s to avoid tissue damage. 20 Mechanical allodynia (von Frey test) was measured using von Frey monofilaments on the left fore-and hind-paws. Mice were placed in plastic chambers above a wire mesh floor, which allowed full access to the fore-and hind-paw. A 1.34 g von Frey filament (Semmes-Weinstein Monofilaments, North Coast Medical Inc., San Jose, CA) was used to produce mechanical tactile stimuli, which were applied to the middle area between the foot pads on the plantar surface of the foreand hind-paws. Each hind paw was probed consecutively by 10 stimulations alternating between the fore-and hind-paws for each set. This was repeated at least five times at intervals of at least 10 min and the final value was obtained by averaging the five measurements. 21, 22 To assess spontaneous pain, the spontaneous pain-related behavior was also measured as described previously. 23 Briefly, the mice were placed in a Plexiglas chamber above a wire mesh floor and allowed to acclimatize for 20 min before the test. Their behaviors were then observed for 5 min. A numerical scale was used to evaluate the degree of spontaneous behavior related to spontaneous pain. The following scale was used in this study: 0 ¼ the paw of the operated side was pressed normally on the floor; 1 ¼ the paw rested lightly on the floor; 2 ¼ only the internal edge of the paw was pressed on the floor; 3 ¼ only the heel was pressed on the floor, and the hind paw was in an inverted position; 4 ¼ the whole paw was elevated; 5 ¼ the animal licked the lesioned paw. The highest score was adopted to estimate the spontaneous painrelated behavior of the tested mice.
The observer was blinded to the treatment regimen received by the mice.
Administration of Drugs and Chemicals
Alendronate (0.02 mg/kg of body weight diluted in physiological saline) (ALN; Merck & Co. Inc., NJ), a potent anti-resorptive agent, was administered to the mice subcutaneously 12 once a day for 2 weeks during tail suspension. Behavioral tests were conducted prior to tail suspension and every week after the start of tail suspension and resumption of weight bearing. Measurement of bone micro-architecture using mCT and the TRAP-5b value of the femoral bone were performed at 2 weeks after the start of tail suspension.
TRPV1 antagonist N-(3-methoxyphenyl)-4-chlorocinnamide (SB366791; BIOMOL International; Plymouth Meeting, PA) and ASIC3 antagonist (APETx2; PEPTIDE Institute, Inc., Osaka, Japan) were used as previously described. 13 In brief, SB366791 was dissolved in 100% dimethyl sulfoxide (DMSO) at a dose of 1 mg/100 ml. SB366791 was intraperitoneally administered at a dose of 1.0 mg/kg, which was diluted in 200 ml of physiological saline, and DMSO at a dose of 50 ml/kg in 200 ml of physiological saline was used as the vehicle. APETx2 was diluted in physiological saline and administered intramuscularly at a dose of 2.2 mM in the left gastrocnemius muscle, with physiological saline used as the vehicle. Behavioral tests were performed at 0 (post-2 week tail suspension), 0.5, 1, and 2 h after the administration of these antagonists.
Statistical Analysis
All data are presented as means AE standard deviation. To determine differences between groups, the measurements were repeated at least three times on one sample, and the individual mean value was used for the statistical analysis. The statistical significance was determined using a Student's t-test and ANOVA. Differences with p-values of <0.05 were considered to be statistically significant.
RESULTS
Anxiety Testing of the Animals
The results of the social interaction test revealed that the number of contacts (80.0 AE 10.5 times), total duration of contacts (68.1 AE 15.7 s), total duration of active contacts (14.8 AE 1.34 s), or mean duration per contact (0.85 AE 0.1 s/one time) in tail-suspended mice did not differ significantly from those in the control mice (73.2 AE 15.9, 68.5 AE 6.3, 15.5 AE 1.4, and 0.94 AE 0.2, respectively) (Fig. 1) .
Regional Transient Osteoporotic Changes in Tail-Suspended Mice mCT measurement of the proximal tibial bone revealed that the BS/BV of tail-suspended mice (mean AE SD, 62.3 AE 2.0) was significantly higher than that of the control mice (56.5 AE 3.9) at 2 weeks (p ¼ 0.029, Fig. 2C ). The Tb.Th of tail-suspended mice (32.1 AE 1.0) was significantly lower than that of the control group (35.5 AE 2.5) at 2 weeks (p ¼ 0.011, Fig. 2D ), and the BV/TV of tail-suspended mice (8.0 AE 0.9) was also significantly lower than that of the control group (11.3 AE 2.3) at 2 weeks (p ¼ 0.005, Fig. 2E ). With regard to the proximal humeral bone, there were no significant differences in BS/BV, Tb.Th, or BV/TV between the tail-suspended (60.9 AE 2.4, 31.2 AE 1.2, and 7.2 AE 0.3, respectively) and control mice (62.3 AE 2.1, 31.6 AE 0.8, and 7.9 AE 0.6, respectively) ( Fig. 2C-E) . Regional osteoporosis was found in the proximal tibia without any changes in the proximal humerus in the tail-suspended mice. In terms of BS/BV and Tb.Th, there were no significant differences between the two types of control mice (data not shown).
There were no significant differences in BS/BV, Tb. Th, or BV/TV at 4 weeks after the resumption of weight bearing between the tail-suspended (51.7 AE 8.3, 39.6 AE 7.5, and 8.0 AE 4.7, respectively) and control mice (58.4 AE 1.2, 34.3 AE 0.7, and 8.0 AE 1.0, respectively) ( Fig. 3A-C) . Consistent with the changes in the bone micro-architecture, the TRAP-5b value (33.4 AE 11.6) and the number of osteoclasts in the bone (7.6 AE 1.5) were significantly increased at 2 weeks after the start of tail suspension (55.5 AE 17.5 and 12.3 AE 1.0, respectively) compared with those of the control mice (33.7 AE 11.3 and 6.7 AE 1.0; p < 0.05, p < 0.001, respectively) ( Fig. 3D and E) . In addition, the increased TRAP-5b values and the number of osteoclasts were significantly decreased to levels comparable to those of the control mice at 4 weeks after the resumption of weight bearing (44.2 AE 17.9 and 8.5 AE 1.5; p < 0.05, p < 0.01, respectively) ( Fig. 3D and E) . Tail suspension caused regional osteoporosis in the hind limbs with increases in bone resorption markers due to osteoclast activation, and the resumption of weight bearing ASIC-RELATED OSTEOPOROTIC BONE PAIN improved the regional osteoporosis accompanied by the inhibition of osteoclast activity (Fig. 3) .
Pain-Like Behavior During Tail Suspension and the Resumption of Weight Bearing
The pain-like behavior on the von Frey tests at 2 (p < 0.05), 3 (p < 0.01), and 4 (p < 0.05) weeks; the paw flick test at 2 and 3 weeks (p < 0.05); and the spontaneous pain-related behavior at 2 (p < 0.01), 3 (p < 0.01), and 4 (p < 0.05) weeks during the 2-week tail suspension and 4-week resumption of weight bearing were significantly higher in comparison with those of the control mice (Fig. 4A-C) . However, the increase in pain-like behaviors in the hind limbs due to the tail suspension were completely recovered at 4 weeks after the resumption of weight bearing. On the other hand, there were no significant changes in pain-like behaviors in the forelimbs during tail suspension and resumed weight bearing (Fig. 4) . With regard to the pain-like behavior, there were no significant differences between the two types of control mice (data not shown).
Effects of Bisphosphonate Treatment on Regional
Osteoporosis and Pain-Like Behavior in Tail-Suspended Mice ALN administration once a day for 2 weeks prevented the increase in BS/BV (mean AE SD, 59.4 AE 3.3), the decrease in Tb.Th (33.8 AE 1.9), and the increase in BV/TV (9.1 AE 0.6) in the proximal tibial bone during tail suspension, with bone values remaining at levels comparable to those in control mice (56.5 AE 3.9, 35.5 AE 2.5, 11.3 AE 2.3, respectively; Fig. 5A-C) . Further, ALN treatment also prevented values were significantly changed by tail suspension for 2 weeks, and recovered by the resumption of weight bearing for 4 weeks after tail suspension (black square, n ¼ 8) in comparison with those for the control mice (white circle, n ¼ 8) (A-C). Tartrate-resistant acid phosphatase-5b (TRAP-5b [U/L]) (D) and the number of osteoclasts (count/1field) in the femoral bone (E) were significantly increased at 2 weeks after the start of tail suspension (black square, n ¼ 4) in comparison with those in the control mice (white circle, n ¼ 4), and were significantly recovered by the resumption of weight bearing for 4 weeks after tail suspension. Duration (weeks), weeks after intervention of tail suspension; tail suspension (arrow), mice were tail-suspended to elevate the hind limbs for unloading for 2 weeks; weight bearing (arrow), after tail suspension, the hind limbs were freed for the resumption of weight bearing for 4 weeks.
Ã p < 0.05, ÃÃ p < 0.01. Tail-suspended mice (black square, n ¼ 8) showed a significant increase in pain-like behaviors in the hind limb on the von Frey test at 2, 3, and 4 weeks during tail suspension and the resumption of weight bearing. The resumption of weight bearing after tail suspension recovered the pain-like behaviors (black square) to the same levels as those in the control mice (white circle, n ¼ 8) (A). With regard to the paw-flick test, the threshold of the hind limb in tail-suspended mice was significantly decreased at 2 and 3 weeks, and was recovered due to the resumption of weight bearing after tail suspension (black square, n ¼ 8) to the same levels as those in the control mice (white circle, n ¼ 8) (B). The spontaneous pain scales of the tail-suspended mice were significantly increased at 2, 3, and 4 weeks, and were recovered due to the re-weight bearing after tail suspension (black square, n ¼ 8) to the same levels as those in the control mice (white circle, n ¼ 8) (C). There were no significant differences in pain-like behaviors in the forelimb between the tail-suspended (black rhombus, n ¼ 8) and control mice (white triangle, n ¼ 8) mice (A, B). Duration (weeks), weeks after intervention of tail suspension; tail suspension (arrow), mice were tail-suspended to elevate the hind limbs for unloading for 2 weeks; weight bearing (arrow), after tail suspension, the hind limbs were freed for the resumption of weight bearing for 4 weeks.
Ã p < 0.05, ÃÃ p < 0.01. ASIC-RELATED OSTEOPOROTIC BONE PAIN increases in TRAP-5b level in tail-suspended mice (Fig. 5D) . The induction of pain-like behavior on the von Frey test in tail-suspended mice was prevented to a significant degree by treatment with ALN at 2 (p < 0.05), 3 (p < 0.01), 4 (p < 0.01), and 5 (p < 0.05) weeks during the 2-week tail suspension and 4-week resumption of weight bearing (Fig. 6A) , with the changes in these values comparable to those in the control mice. The induction of the pain in the paw flick test was significantly prevented by ALN treatment at 3 weeks of the 2-week tail suspension and 4-week resumption of weight bearing (p < 0.01, Fig. 6B) , and that at 2, 4, 5, and 6 weeks also tended to be improved although there were no significant differences (Fig. 6B) . The induction of pain-like behavior, as assessed on the spontaneous scale in tail-suspended mice was significantly prevented by treatment with ALN at 2, 3, and 4 (p < 0.05) weeks of the 6-week study period (Fig. 6C ).
Inhibitory Effects of the TRPV1 and ASIC3 Antagonists on Pain-Like Behavior in Tail-Suspended Mice SB366791, a TRPV1 antagonist, and APETx2, a selective blocker of ASIC3, were intraperitoneally administered to mice at 2 weeks after the start of tail suspension, at which time point a significant induction in pain-like behavior in the hind limb was observed. SB366791 improved the pain-like behavior on the von Frey test (Fig. 7A) at 0.5 and 1 h after administration (p < 0.05), and that on the paw flick test was tended to be improved although there was no statistical significance (Fig. 7B) . On the other hand, there were no significant differences in pain-like behaviors in the forelimb among the tail-suspension mice with or without SB366791 treatment, and control mice ( Fig. 7C and D) . Similarly, APETx2 significantly improved the pain-like behavior in the hind limb on the von Frey test and the paw flick test in tailsuspended mice at 0.5, 1, and 2 h after administration (p < 0.05, Fig. 8A and B) ; however, the agent had no significant effect on the pain-like behavior in the forelimb (Fig. 8C and D) .
DISCUSSION
Previous clinical studies have demonstrated that findings of regional osteoporosis in the affected limb contribute to skeletal pain, which is improved by the bisphosphonate treatment, under the pathological conditions such as CRPS, 10, 11, 15 transient osteoporosis of the hip, 5, 8 and regional migratory osteoporosis. 4, 9 However, the pathogenesis of skeletal pain related to regional osteoporosis remains to be clarified. Several studies have indicated that microtrauma or noxious tissue stimuli could cause microscopic trabecular fractures, which trigger a reparative response. These responses result in an acceleratory increase in the regional biological metabolism and turnover including blood flow, cell turnover, and tissue remodeling; and Figure 6 . Effects of ALN on pain-like behaviors in tail-suspended mice. Treatment with ALN (cross mark, n ¼ 8) at a 0.02 mg/kg per day for 2 weeks significantly prevented the induction of pain-like behaviors in tail-suspended mice compared with those observed in the mice without the treatment (black square, n ¼ 8) (A-C). The pain-like behaviors on the von Frey test (A) at 2, 3, 4, and 5 weeks, on the paw-flick test (B) at 3 weeks, and on the spontaneous scale (C) at 2, 3, and 4 weeks during the 2-week tail suspension and 4-week resumption of weight bearing were remained at levels comparable to those in the control mice (white circle, n ¼ 8). Duration (weeks), weeks after intervention of tail suspension; tail suspension (arrow), mice were tail-suspended to elevate the hind limbs for unloading for 2 weeks; weight bearing (arrow), after tail suspension, the hind limb were freed for the resumption of weight bearing for 4 weeks; ALN (arrow), 2 week treatment with alendronate during tail suspension.
these phenomenon induce regional osteoporotic changes. 5, 24, 25 On the other hand, a recent study has demonstrated the presence of osteoclast activation in bone biopsy specimens from transient regional osteoporosis patients, and this condition was improved by treatment with bisphosphonate. 8 Our previous clinical report also showed that severe skeletal pain in the foot or ankle in CRPS I patients with regional osteoporosis was improved by treatment with bisphosphonate. In addition, the recovery of regional osteoporosis and reduction of a bone resorption markers, such as TRAP5b, by bisphosphonate treatment were related to improvements in skeletal pain. 11 We, therefore, hypothesized that the pathological changes that occur in the presence of osteoclast activation causing the formation of an acidic microenvironment 12 in regional osteoporosis might be one of the causes of skeletal pain.
In this study, the proximal tibia in the hind limb of mice showed significant changes associated with regional osteoporotic findings at 2 weeks during tail suspension, whereas the proximal humerus in the forelimb did not reveal any significant changes. The osteoporotic findings for the tibia were significantly improved by the resumption of weight bearing, with a complete recovery of the regional osteoporotic changes was attained at 4 weeks after the resumption of weight bearing. In addition, the osteoporotic changes Figure 7 . Effects of SB366791 on pain-like behaviors in tail-suspended mice. The von Frey test showed that SB366791 (1 mg/kg) significantly improved the pain-like behaviors of the hind limb in tail-suspended mice (black rhomboid, n ¼ 8) in comparison with those in the mice with vehicle treatment (black square, n ¼ 8) at 0.5 and 1 h after treatment, with levels remaining comparable to those in the control mice (white circle, n ¼ 8) (A). The paw-flick test showed that SB366791 improved the pain-like behaviors of the hind limb in tail-suspended mice at 0.5 and 1 h after administration, although the differences were not significant (B). In the forelimb, there were no significant differences in pain-like behaviors among the tail-suspension mice with or without SB366791 treatment, and control mice ( Fig. 7C and D) . SB366791, a TRPV1 antagonist; Ã p < 0.05. Figure 8 . Effects of APETx2 on pain-like behaviors in tail-suspended mice. The von Frey test showed that APETx2 (2.2 mg) significantly improved the pain-like behaviors of the hind limb in tail-suspended mice (black triangle, n ¼ 8) compared with those in the mice with vehicle treatment (black square, n ¼ 8) for 2 h after treatment, with levels remaining comparable to those in the control mice (white circle, n ¼ 8) (A). Similarly, the paw flick test showed that APETx2 (2.2 mg) significantly improved the pain-like behaviors in tail-suspended mice (black triangle) compared with those in the mice with vehicle treatment (black square) for 2 h after the treatment (B). In the forelimb, there were no significant differences in pain-like behaviors among the tail-suspension mice with or without APETx2 treatment, and control mice ( Fig. 7C and D) . APETx2, an ASIC3 antagonist; Ã p < 0.05, ÃÃ p < 0.01. Regarding the evaluation of the skeletal pain in the tail-suspended mice, we used the von Frey test for measuring mechanical allodynia and the paw-flick test for measuring thermal hyperalgesia, as previously described. 12, 20 While those tests for pain-like behaviors in mice have not been established as surrogate methods for measuring skeletal pain, our previous study demonstrated that c-Fos expression in the spinal cord, which is a functional marker of nociception, 27 was increased in accordance with the induction of those pain-like behaviors in an OVX mouse model. 12 In addition, we also found that the increased c-Fos expression at the dorsal horn of the L4-5 level in the spinal cord was correlated to the activation of microglia or astrocytes which function to regulate the areas around sensory neurons and set up networks among the sensory neurons in those areas [12 and unpublished data] . We, therefore, hypothesize that those reactive microglia and astrocytes affect the activation of other sensory neurons in those areas of the spinal cord, and the activation of other sensory neurons might cause a lowering of the threshold for pain-like behavior such as mechanical allodynia and thermal hyperalgesia of the limbs. The results of the spontaneous pain-like behavior test in the present study were also consistent with those of the von Frey test and paw-flick test. Thus, we believe that those pain-like behavior tests might be surrogate methods for evaluating skeletal pain in the tail-suspended mouse model, although further experiments, such as electrophysiological examinations, are needed. 23 With regard to clinical practice, most osteoporosis patients do not reveal spontaneous skeletal pain without fractures or skeletal deformities. However, it is unclear whether the skeletal pain threshold in osteoporosis patients is lower than that in normal subjects. Interestingly, a previous epidemiologic study on research on knee osteoarthritis indicated that the prevalence of knee pain in elderly female patients was higher than that in elderly males even at the same stage of osteoarthritis as evaluated by roentgenogram findings. 28 These results seem to indicate that the threshold of knee pain in post-menopausal female patients, a number of whom will reveal osteoporotic changes, is lower than that in male patients. We, therefore, speculate the possibility that osteoarthritis patients with osteoporosis might complain of skeletal pain more frequently than those without osteoporosis. Further evaluation of the skeletal pain threshold for those patients is needed to elucidate the underlying mechanism.
We have demonstrated that the direct inhibition of acid-sensing nocicepotors, such as TRPV1 or ASICs, using antagonists could improve pain-like behaviors in tail-suspended mice in the same manner as in OVX mice. 13 Although the mechanism of osteoporosis induction in the tail-suspended mouse model is different from that in the OVX mouse model, we speculate that the formation of an acidic environment in the bone tissue due to osteoclast activation might be a trigger for skeletal pain accompanied by regional transient osteoporosis. To our knowledge, this is the first report describing the mechanism underlying the onset of pain-like behaviors related to regional transient osteoporosis using a tail-suspended mouse model. Interestingly, the administration of bisphosphonate for 2 weeks during tail suspension had a significant effect in terms of the prevention of the onset of painlike behaviors, and the effect remained at 4 weeks after the discontinuation of bisphosphonate treatment. These results indicated that the pre-administration of bisphosphonate might be effective in preventing the skeletal pain accompanying regional osteoporosis in association with several skeletal disorders including nonweight bearing after trauma, osteoarthritis, and orthopedic procedures. 11, 24 In addition, treatment with TRPV1 and ASIC3 antagonists significantly and rapidly improved the pain-like behaviors in mouse hind limbs caused by tail suspension, whereas the antagonists had no significant effect on those in the forelimb. These results also indicated that antagonists to TRPV1 or ASIC3 might be potential agents for improving skeletal pain related to pathological conditions associated with regional osteoporosis, such as transient osteoporosis of hip, regional migratory osteoporosis, and CRPS. On the other hand, the previous study indicated that the TRPV1 antagonist caused the side effects such as hyperthermia due to increase of heat pain thresholds. 29 Then, we need further experiments for the clinical application of those antagonist in future studies.
The present study has several limitations. First, we used the von Frey test and paw-flick test to evaluate skeletal pain in the tail-suspended mice; however, those tests for pain-like behaviors have not yet been established as surrogate methods for measuring skeletal pain. Second, the tail-suspended and weight bearing-resumed mouse model does not exactly reflect transient osteoporosis of hip, regional migratory osteoporosis, or CRPS as those diseases are self-limiting disorders. 30 Third, we did not directly demonstrate an increase in acidic environment formation by histological analysis in the tail-suspended mice. Fourth, we have only shown the short-term effects of nociceptor antagonists on pain-like behaviors in tail-suspended mice. Fifth, we did not examine the roles of osteoblasts and osteocytes in relation to the pain-like behavior in the tail-suspended mice as these cells are thought to be involved in the genesis of unloading osteoporosis. We, therefore, believe additional studies are needed to further elucidate the mechanisms underlying the relationship between regional osteoporosis and bone pain in skeletal refractory pain disease.
In conclusion, we demonstrated that pain-like behaviors in tail-suspended mice were significantly increased in comparison with those in control mice. These tail-suspended mice also showed regional osteoporotic changes in the hind limbs accompanied by an increase in bone resorption due to osteoclast activation. The pain-like behaviors accompanying the regional osteoporotic changes were significantly improved by the resumption of weight bearing, or treatment with bisphosphonate or acid-sensing nociceptor antagonists.
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